BTIS
UTHR icon

BB&T Investment Services’s United Therapeutics UTHR Stock Holding History

BB&T Investment Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$111K Hold
750
– – 0.02% 380
2017
Q3 		$88K Hold
750
– – 0.02% 400
2017
Q2 		$97K Sell
750
-17
-2% -$2.12K 0.02% 327
2017
Q1 		$104K Buy
767
+17
+2% +$2.58K 0.04% 262
2016
Q4 		$108K Buy
+750
New +$95.8K 0.08% 199

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BB&T Investment Services's UTHR Position: Q4 2017 in Review

BB&T Investment Services held its United Therapeutics (UTHR) position steady in Q4 2017 at 750 shares worth $111K. The position accounts for 0.02% of the portfolio, ranked #380.

BB&T Investment Services first reported a position in UTHR in Q4 2016 and has held it in 5 quarters since. 400 funds tracked by Wall St. Rank hold UTHR as of Q4 2017.

  • BB&T Investment Services held 750 shares of United Therapeutics worth $111K as of Q4 2017.
  • BB&T Investment Services left its United Therapeutics share count unchanged in Q4 2017.
  • United Therapeutics made up 0.02% of BB&T Investment Services's portfolio in Q4 2017, its #380 holding.
  • BB&T Investment Services first reported a position in United Therapeutics in Q4 2016 and has held it in 5 quarters since.
  • 400 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.